Subsequently, Hodges et al. demonstrated that suPAR can outperform traditional inflammatory markers, such as C-reactive protein (CRP), as a biomarker for cardiovascular disease in the prediction of the risk of CVD development (Hodges et al., 2015). Here, CRP is linked to cardiovascular disorder.